Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
Biochem Pharmacol
; 137: 29-50, 2017 08 01.
Article
en En
| MEDLINE
| ID: mdl-28476333
Palabras clave
(1E,6E)-4-(3-Bromo-4-hydroxy-5-methoxybenzylidene)-1,7-bis(345-trimethoxyphenyl)hepta-1,6-diene-3,5-dione (33: PubChem CID:123132175); (1E,6E)-4-(4-Hydroxy-3,5-dimethoxybenzylidene)-1,7-bis(3,4,5-trimethoxyphenyl)hepta-1,6-diene-3,5-dione (34: PubChemCID:123132176); 19S regulatory particle; 3,4,5-Trimethoxybenzaldehyde (PubChem CID:6858); Acetylacetone (PubChem CID: 31261); Anticancer; Bortezomib (PubChem CID: 387447); Curcumin (PubChem CID: 969516); Curcumin analogues; Deubiquitinase; Proteasome; n-Butylamine (PubChem CID: 8007)
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Curcumina
/
Complejo de la Endopetidasa Proteasomal
/
Inhibidores de Proteasoma
/
Enzimas Desubicuitinizantes
/
Antineoplásicos
Tipo de estudio:
Diagnostic_studies
/
Risk_factors_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Biochem Pharmacol
Año:
2017
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
Reino Unido